{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:09:02Z","timestamp":1764331742234},"reference-count":20,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[1980,2,1]]},"DOI":"10.1136\/jnnp.43.2.171","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T21:16:40Z","timestamp":1226351800000},"page":"171-174","source":"Crossref","is-referenced-by-count":45,"title":["Fluvoxamine and clomipramine in the treatment of cataplexy."],"prefix":"10.1136","volume":"43","author":[{"given":"M","family":"Schachter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J D","family":"Parkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"issue":"44","key":"ref_1","first-page":"953","volume":"1960","author":"RE, I.Yoss; DD, Daly","unstructured":"I Yoss RE, Daly DD. Narcolepsy. Med Clin North Am 1960; 44:953-68.","journal-title":"Narcolepsy. Med Clin North Am"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0404.1975.tb05830.x","article-title":"Natural history, symptoms and treatment of the narcoleptic syndrome","volume":"52","author":"Parkes, J.D.; Baraitser, M.; Marsden, C.D.; Asselman, P.","year":"1975","unstructured":"Parkes JD, Baraitser M, Marsden CD, Asselman P. Natural history, symptoms and treatment of the narcoleptic syndrome. A cta Neurol Scand 1975; 52:337-53.","journal-title":"A cta Neurol Scand"},{"key":"ref_3","first-page":"1","article-title":"Pharmacology in narcolepsy","volume":"21","author":"Akimoto, H.; Honda, Y.; Takahashi, Y.","year":"1960","unstructured":"Akimoto H, Honda Y, Takahashi Y. Pharmacology in narcolepsy. Dis Nerv Syst 1960; 21: 1-3.","journal-title":"Dis Nerv Syst"},{"issue":"2","key":"ref_4","first-page":"467","article-title":"Preliminary pharmacological and and clinical results with desmethylimipramine (DMI) G-35020, a metabolite of imipramine","volume":"1961","author":"Brodie, B.; Dick, P.; Kielholz, P.; Poldinger, W.; Theobald, W.","unstructured":"Brodie B, Dick P, Kielholz P, Poldinger W, Theobald W. Preliminary pharmacological and and clinical results with desmethylimipramine (DMI) G-35020, a metabolite of imipramine. Psychopharmacology 1961; 2:467-74.","journal-title":"Psychopharmacology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0022-510X(66)90001-3","article-title":"Treatment of narcolepsy with imipramine (Tofranil) and desmethylimipramine (Pertofran)","volume":"3","author":"Hishikawa, Y.; Ida, H.; Nakai, K.; Kaneko, Z.","year":"1966","unstructured":"Hishikawa Y, Ida H, Nakai K, Kaneko Z. Treatment of narcolepsy with imipramine (Tofranil) and desmethylimipramine (Pertofran). J Neurol Sci 1966; 3:453-61.","journal-title":"J Neurol Sci"},{"key":"ref_6","first-page":"56","article-title":"Etat de mal cataplectique au cours d'une maladie de Gelineau; influence de la clomipramine","volume":"123","author":"Passouant, P.; Baldy-Moulinier, M.; Aussilloux, C.","year":"1970","unstructured":"Passouant P, Baldy-Moulinier M, Aussilloux C. Etat de mal cataplectique au cours d'une maladie de Gelineau; influence de la clomipramine. Rev Neurol [Paris] 1970; 123:56-60.","journal-title":"Rev Neurol [Paris]"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/030006057300100530","article-title":"Clomipramine (Anafranil) in the treatment of cataplexy","volume":"1","author":"Parkes, J.D.","year":"1973","unstructured":"Parkes JD. Clomipramine (Anafranil) in the treatment of cataplexy. J Int Med Res 1973; 1:427-31.","journal-title":"J Int Med Res"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archneur.1975.00490520023002","article-title":"Treatment of cataplexy with clomipramine","volume":"32","author":"Shapiro, W.R.","year":"1975","unstructured":"Shapiro WR. Treatment of cataplexy with clomipramine. Arch Neurol 1975; 32:653-6.","journal-title":"Arch Neurol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archneur.1974.00490400069008","article-title":"A study on cataplexy","volume":"31","author":"Guilleminault, C.; Wilson, R.A.; Dement, W.C.","year":"1974","unstructured":"Guilleminault C, Wilson RA, Dement WC. A study on cataplexy. Arch Neurol 1974; 31:255-61.","journal-title":"Arch Neurol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0404.1976.tb07621.x","article-title":"Evaluation of shortterm and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride","volume":"54","author":"Guilleminault, C.; Raynal, D.; Takahashi, S.; Carskadon, M.; Dement, W.C.","year":"1976","unstructured":"Guilleminault C, Raynal D, Takahashi S, Carskadon M, Dement WC. Evaluation of shortterm and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride. Acta Neurol Scand 1976; 54:71-87.","journal-title":"Acta Neurol Scand"},{"key":"ref_11","first-page":"1289","article-title":"Tricyclic antidepressants: mode of action","volume-title":"a generation of progress","author":"l Kessler KA, I.","year":"1978","unstructured":"I l Kessler KA. Tricyclic antidepressants: mode of action. In: Lipton MA, DiMascio A, Killen KF, eds. Psychopharmacology, a generation of progress. New York: Raven Press, 1978; 1289-96."},{"key":"ref_12","first-page":"499","article-title":"Oral 5-hydroxytryptophan effects on sleep","author":"Zarcone, V.; Hoddes, E.; Smythe, H.","year":"1973","unstructured":"Zarcone V, Hoddes E, Smythe H. Oral 5-hydroxytryptophan effects on sleep. In: Barchas J, Usdin E, eds. Serotin and behaviour. New York: Academic Press, 1973; 499-599."},{"key":"ref_13","first-page":"33","article-title":"The serotonin-catecholamine dream bicycle: a clinical study","volume":"5","author":"Wyatt, R.J.","year":"1972","unstructured":"Wyatt RJ. The serotonin-catecholamine dream bicycle: a clinical study. Biol Psychiatry 1972; 5:33-63.","journal-title":"Biol Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0028-3908(74)90054-9","article-title":"The blockade of bulbospinal inhibition by imipramine, desipramine and pargyline","volume":"13","author":"Sinclair, J.G.; Sastry, B.S.R.","year":"1974","unstructured":"Sinclair JG, Sastry BSR. The blockade of bulbospinal inhibition by imipramine, desipramine and pargyline. Neuropharmacology 1974; 13:643-50.","journal-title":"Neuropharmacology"},{"key":"ref_15","first-page":"366","article-title":"The interpretation of responses of motor neurone field potentials to 5-hydroxytryptamine","volume":"54","year":"1975","unstructured":"Barasi S, Parry 0, Roberts MHT. The interpretation of responses of motor neurone field potentials to 5-hydroxytryptamine. Br J Pharmacol. 1975; 54:366-7.","journal-title":"Br J Pharmacol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1476-5381.1977.tb07528.x","article-title":"Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor","volume":"60","author":"Claassen, V.; Davies, J.E.; Hertting, G.; Plancheta, P.","year":"1977","unstructured":"Claassen V, Davies JE, Hertting G, Plancheta P. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol 1977; 60:505-17.","journal-title":"Br J Pharmacol"},{"key":"ref_17","first-page":"56","article-title":"Fluvoxamine-a new serotonin reuptake inhibitor: first clinical and psychometric experiences in depressed patients","volume":"41","author":"Saletu, B.; Schjerve, M.; Grunberger, J.; Schanda, H.; Arnold, O.H.","year":"1977","unstructured":"Saletu B, Schjerve M, Grunberger J, Schanda H, Arnold OH. Fluvoxamine-a new serotonin reuptake inhibitor: first clinical and psychometric experiences in depressed patients. J Neural Transm 1977; 41:56-66.","journal-title":"J Neural Transm"},{"key":"ref_18","first-page":"387","article-title":"Towards an animal model of narcolepsy\/cataplexy","author":"Mittler, M.R.","year":"1976","unstructured":"Mittler MR. Towards an animal model of narcolepsy\/cataplexy. In: Guilleminault C, Dement WC, Passouant P, eds. Narcolepsy. New York: Spectrum Publications, 1976; 387-99."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/ajp.134.2.183","article-title":"Protriptyline: an effective agent in the treatment of the narcolepsy-cataplexy syndrome and hypersomnia","volume":"134","year":"1977","unstructured":"Schmidt HS, Clark RW, Hyman PR. Protriptyline: an effective agent in the treatment of the narcolepsy-cataplexy syndrome and hypersomnia. Am J Psychiatry 1977; 134:183-5.","journal-title":"Am J Psychiatry"},{"key":"ref_20","first-page":"62","article-title":"Single dose studies with clomipramine in normal subjects","volume":"52","author":"Jones, R.B.; Luscombe, D.K.","year":"1976","unstructured":"Jones RB, Luscombe DK. Single dose studies with clomipramine in normal subjects. Postgr Med J 1976; 52:62-7.","journal-title":"Postgr Med J"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.43.2.171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T03:49:18Z","timestamp":1601092158000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.43.2.171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,2,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1980,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.43.2.171","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[1980,2,1]]}}}